BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9710254)

  • 1. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
    Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts JP; De Clercq E; De Meester I; Van Damme J
    FEBS Lett; 1998 Jul; 432(1-2):73-6. PubMed ID: 9710254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.
    Shioda T; Kato H; Ohnishi Y; Tashiro K; Ikegawa M; Nakayama EE; Hu H; Kato A; Sakai Y; Liu H; Honjo T; Nomoto A; Iwamoto A; Morimoto C; Nagai Y
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6331-6. PubMed ID: 9600965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.
    Ohtsuki T; Hosono O; Kobayashi H; Munakata Y; Souta A; Shioda T; Morimoto C
    FEBS Lett; 1998 Jul; 431(2):236-40. PubMed ID: 9708910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
    Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
    Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
    Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
    Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
    Proost P; De Meester I; Schols D; Struyf S; Lambeir AM; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
    J Biol Chem; 1998 Mar; 273(13):7222-7. PubMed ID: 9516414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
    Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
    Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.
    Christopherson KW; Hangoc G; Broxmeyer HE
    J Immunol; 2002 Dec; 169(12):7000-8. PubMed ID: 12471135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comodulation of CXCR4 and CD26 in human lymphocytes.
    Herrera C; Morimoto C; Blanco J; Mallol J; Arenzana F; Lluis C; Franco R
    J Biol Chem; 2001 Jun; 276(22):19532-9. PubMed ID: 11278278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
    Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
    Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.
    Narducci MG; Scala E; Bresin A; Caprini E; Picchio MC; Remotti D; Ragone G; Nasorri F; Frontani M; Arcelli D; Volinia S; Lombardo GA; Baliva G; Napolitano M; Russo G
    Blood; 2006 Feb; 107(3):1108-15. PubMed ID: 16204308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
    Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
    J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.
    Heveker N; Montes M; Germeroth L; Amara A; Trautmann A; Alizon M; Schneider-Mergener J
    Curr Biol; 1998 Mar; 8(7):369-76. PubMed ID: 9545196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.
    Sadir R; Imberty A; Baleux F; Lortat-Jacob H
    J Biol Chem; 2004 Oct; 279(42):43854-60. PubMed ID: 15292258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.
    Bleul CC; Farzan M; Choe H; Parolin C; Clark-Lewis I; Sodroski J; Springer TA
    Nature; 1996 Aug; 382(6594):829-33. PubMed ID: 8752280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
    Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
    Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets.
    Kowalska MA; Ratajczak J; Hoxie J; Brass LF; Gewirtz A; Poncz M; Ratajczak MZ
    Br J Haematol; 1999 Feb; 104(2):220-9. PubMed ID: 10050701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
    Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
    J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells.
    Christopherson KW; Cooper S; Broxmeyer HE
    Blood; 2003 Jun; 101(12):4680-6. PubMed ID: 12576320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.
    Proost P; Struyf S; Schols D; Opdenakker G; Sozzani S; Allavena P; Mantovani A; Augustyns K; Bal G; Haemers A; Lambeir AM; Scharpé S; Van Damme J; De Meester I
    J Biol Chem; 1999 Feb; 274(7):3988-93. PubMed ID: 9933589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.